Catalytic life of activated factor XIII in thrombi: Implications for fibrinolytic resistance and thrombus aging

Circulation

Volumn 102, Issue 10, 2000, Pages 1151-1157

  Robinson, Brian R ^a   Houng, Aiilyan K ^a   Reed, Guy L ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Embolism; Fibrinolysis; Thrombus

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 13; FIBRIN; GLUTAMINE; PENTYLAMINE; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; FERRET; LUNG EMBOLISM; MALE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; THROMBUS;

EID: 0034609554     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.10.1151     Document Type: Article

References (25)

1. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow 'patency' (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials)
2. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
3. The Thrombolysis in Myocardial Infarction (TIMI) trial: Phase I fiodings
4. Treatment of venous thromboembolism
5. The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism
6. Calcium and blood coagulation
7. Effects of calcium ions and covalent cross-linking on formation and elasticity of fibrin gels
8. Rigidity of fibrin gels as measured by quasielastic light scattering
9. Novel aspects of blood coagulation factor XIII, I: Structure, distribution, activation, and function
10. 2-plasmin inhibitor of fibrin by fibrin-stabilizing factor
11. Progressive cross-linking of fibrin γ chains increases resistance to fibrinolysis
12. Crosslinking of rabbit fibrin in vivo
13. 2-antiplasmin to fibrin
14. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody
15. 2-Antiplasmin causes thrombi to resist fibrinolysis induced by tissue plasminogen activator in experimental pulmonary embolism
16. 2-plasmin inhibitor to fibrin
17. 2-plasmin inhibitor
18. Fibrin subunits in venous and arterial thromboembolism
19. Stereochemical aspects of amine substrate attachment to acyl intermediates of transglutaminases: Human blood plasma enzyme (activated coagulation factor XIII) and guinea pig liver enzyme
20. The half-life of factor XIII in the management of inherited deficiency
21. Role of histidine 373 in the catalytic activity of coagulation factor XIII
22. Structural features of glutamine substrates for transglutaminases: Specificities of human plasma factor XIIIa and the guinea pig liver enzyme
23. Human factor XIII: Fibrin stabilizing factor
24. Association of a common polymorphism in the factor XIII gene with venous thrombosis
25. 2-plasmin inhibitor to fibrin catalysed by activated fibrin-stabilizing factor